These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26886616)

  • 21. [Metformin can reduce the risk of colorectal cancer].
    Fransgård T; Gögenur I
    Ugeskr Laeger; 2015 May; 177(21):V12140659. PubMed ID: 26027593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.
    Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H
    Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.
    Ipsen EØ; Madsen KS; Chi Y; Pedersen-Bjergaard U; Richter B; Metzendorf MI; Hemmingsen B
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013516. PubMed ID: 33210751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
    Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
    Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
    Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin and Colorectal Cancer - A Systematic Review.
    Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T
    Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.
    Zhang ZJ; Zheng ZJ; Kan H; Song Y; Cui W; Zhao G; Kip KE
    Diabetes Care; 2011 Oct; 34(10):2323-8. PubMed ID: 21949223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
    Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
    Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis.
    Hou YC; Hu Q; Huang J; Fang JY; Xiong H
    Oncotarget; 2017 Jan; 8(5):8843-8853. PubMed ID: 27903961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis.
    Yao L; Liu M; Huang Y; Wu K; Huang X; Zhao Y; He W; Zhang R
    Dis Markers; 2019; 2019():6230162. PubMed ID: 30881522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
    Chen CH; Lin CL; Hsu CY; Kao CH
    QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis.
    Hu J; Fan HD; Gong JP; Mao QS
    BMC Gastroenterol; 2023 Feb; 23(1):50. PubMed ID: 36829129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus.
    Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N
    Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
    Zhang H; Gao C; Fang L; Zhao HC; Yao SK
    Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
    Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
    [No Abstract]   [Full Text] [Related]  

  • 36. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
    Mekuria AN; Ayele Y; Tola A; Mishore KM
    J Diabetes Res; 2019; 2019():7676909. PubMed ID: 31828167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
    Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR
    J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postdiagnostic metformin use and survival of patients with colorectal cancer: A Nationwide cohort study.
    Huang WK; Chang SH; Hsu HC; Chou WC; Yang TS; Chen JS; Chang JW; Lin YC; Kuo CF; See LC
    Int J Cancer; 2020 Oct; 147(7):1904-1916. PubMed ID: 32196659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus.
    Madsen KS; Kähler P; Kähler LKA; Madsbad S; Gnesin F; Metzendorf MI; Richter B; Hemmingsen B
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012368. PubMed ID: 30998259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.